Skip to content
10-K

Annual Report

Cell Source, Inc. CLCS

0001493152-23-027069

← back to feed
Filed
Aug 8, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Aug 1, 2023 38.16M sh
Cash And Equivalents FY 2022 · Dec 31, 2022 $222.67K
Cash And Equivalents FY 2022 · Dec 31, 2021 $93.1K
Rd Expense FY 2022 · Dec 31, 2022 $1.94M
Rd Expense FY 2022 · Dec 31, 2021 $1.27M
Shares Diluted FY 2022 · Dec 31, 2021 33.12M sh
Operating Cash Flow FY 2022 · Dec 31, 2021 −$3.38M
Total Liabilities FY 2022 · Dec 31, 2021 $10.14M
Total Assets FY 2022 · Dec 31, 2021 $313.77K
Eps Diluted FY 2022 · Dec 31, 2021 −$0.19
Eps Basic FY 2022 · Dec 31, 2021 −$0.19
Net Income FY 2022 · Dec 31, 2021 −$5.47M
Operating Income FY 2022 · Dec 31, 2021 −$4.02M
Stockholders Equity FY 2022 · Dec 31, 2020 −$7.95M